Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Schizophrenic symptoms and dietary intake of n-3 fatty acids.

× No keyword cloud information.

10 in total

Review 1. Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors: Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal: World J Psychiatry Date: 2015-03-22

Review 2. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission.

Authors: S Chalon; S Vancassel; L Zimmer; D Guilloteau; G Durand
Journal: Lipids Date: 2001-09 Impact factor: 1.880

Review 3. Polyunsaturated fatty acid supplementation for schizophrenia.

Authors: C B Joy; R Mumby-Croft; L A Joy
Journal: Cochrane Database Syst Rev Date: 2006-07-19

4. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

Authors: Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Chang-Gyu Hahn; Neil M Richtand; Kevin E Stanford
Journal: Schizophr Res Date: 2007-01-19 Impact factor: 4.939

5. Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors: Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal: Mol Neurobiol Date: 2017-05-17 Impact factor: 5.590

6. Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors: Robert K McNamara; Jeffrey R Strawn
Journal: PharmaNutrition Date: 2013-04

7. Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia.

Authors: Susan J van Rensburg; Cornelius M Smuts; Dinie Hon; Martin Kidd; Sulene van der Merwe; Christo Myburgh; Piet Oosthuizen; Robin Emsley
Journal: Metab Brain Dis Date: 2009-10-14 Impact factor: 3.584

8. Randomized, placebo-controlled clinical trial of omega-3 as supplemental treatment in schizophrenia.

Authors: Hamidreza Jamilian; Hasan Solhi; Mehri Jamilian
Journal: Glob J Health Sci Date: 2014-09-18

Review 9. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation.

Authors: Erik Messamore; Robert K McNamara
Journal: Lipids Health Dis Date: 2016-02-10 Impact factor: 3.876

Review 10. The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.

Authors: Carlo Agostoni; Maria Nobile; Valentina Ciappolino; Giuseppe Delvecchio; Alessandra Tesei; Stefano Turolo; Alessandro Crippa; Alessandra Mazzocchi; Carlo A Altamura; Paolo Brambilla
Journal: Int J Mol Sci Date: 2017-12-04 Impact factor: 5.923

10 in total